High Tide to Present at Several Major International Cannabis and Investor Conferences

Rhea-AI Summary

High Tide (Nasdaq: HITI) announced senior executives and advisors will speak at multiple cannabis and investor conferences in Europe and North America between April and June 2026.

Planned appearances include Berlin (April 13–14), New York (May 7, June 2), London (May 26) and Las Vegas (June 17). The company highlights its retail scale (Canna Cabana: 220 Canadian locations, 1 international) and medical distribution reach (Remexian licensed to import from 19 countries).

Market Context

This announcement outlines an extensive conference schedule for High Tide’s leadership across North ...

Analysis

This announcement outlines an extensive conference schedule for High Tide’s leadership across North America and Europe, emphasizing cannabis policy, investment opportunities, and M&A themes. It reinforces the company’s position as a large cannabis retailer with 220 Canadian locations, a 12% domestic market share, and medical distribution into 19 countries via Remexian. Investors may monitor how this visibility campaign translates into partnership activity, deal flow, and incremental growth alongside previously reported record revenues.

Key Figures

Current share price: $2.33 Price change: 2.19% 52-week high: $4.0554 +5 more

8 metrics

Current share price $2.33 Prior to publication on 2026-04-13

Price change 2.19% 24h move prior to news

52-week high $4.0554 Pre-news trading range

52-week low $1.66 Pre-news trading range

Canna Cabana locations Canada 220 stores Canadian retail footprint

International Canna Cabana 1 store First international retail location

Canadian market share 12% Canna Cabana Canadian cannabis retail share

Remexian import countries 19 countries Licensed medical cannabis import network

Historical Context

5 past events · Latest: Apr 01 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 01	CBD pilot pursuit	Positive	-0.9%	NuLeaf Naturals aims to join a new U.S. Medicare CBD pilot program.
Mar 17	Q1 2026 earnings	Positive	-1.6%	Record quarterly revenue, gross profit and positive free cash flow reported.
Mar 06	Store expansion	Positive	-0.4%	Opened 220th Canna Cabana store, reinforcing Canadian footprint and share.
Mar 04	Policy council role	Positive	-1.2%	Joined U.S. National Compassionate Care Council as founding member.
Mar 03	Board refresh	Positive	-0.8%	Added new directors and advisors with AI and real estate expertise plus equity grants.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history shows a pattern of mildly negative price reactions to generally positive operational and strategic updates, suggesting a tendency for good news to be faded.

Recent Company History

Over the last few months, High Tide has reported record Q1 FY2026 revenue of $178.3M, expanded its Canna Cabana network to 220 Canadian locations and ~12% domestic share, pursued U.S. Medicare-related CBD pilots, and joined a U.S. compassionate care council. It also refreshed its board and added AI and real estate expertise, alongside new RSU and option grants. Despite these constructive developments, the stock saw small negative moves after each release, framing today’s conference-focused news against a backdrop of underappreciated operational progress.

Key Terms

medical cannabis, cbd, m&a, edgar, +1 more

5 terms

medical cannabis medical

"importation and wholesale of medical cannabis products at affordable prices."

Medical cannabis is the use of cannabis plant extracts or compounds such as THC and CBD as prescribed or recommended to treat symptoms or medical conditions. Think of it as a plant-based medicine that can relieve pain, nausea, muscle spasms or other symptoms where conventional drugs may not work; for investors it matters because legal status, clinical evidence, supply rules and insurance coverage determine market size, licensing value and revenue potential.

cbd medical

"global e-commerce platforms offering accessories and hemp-derived CBD products."

Cannabidiol (CBD) is a natural compound found in hemp and cannabis plants that does not produce the “high” associated with THC. Investors care because CBD is sold in a wide range of consumer products and medical treatments, so changes in regulation, clinical evidence, or consumer demand can quickly affect company sales, margins and legal risk — think of it as a product line whose value depends on shifting rules and public trust.

m&a financial

"Deal Flow & Due Diligence: Inside Europe's Next M&A Wave – 14:00 (GMT+1)"

M&A, short for mergers and acquisitions, involves one company combining with or purchasing another company to grow, streamline operations, or gain competitive advantages. For investors, M&A activity can signal potential for increased value, new opportunities, or changes in market dynamics, making it an important factor to watch in the business landscape.

View in glossary

edgar regulatory

"For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR."

EDGAR is a system used by companies to share important financial and business information with the public. It functions like an online filing cabinet where investors can access official reports and documents that help them understand a company's financial health and operations. This transparency allows investors to make more informed decisions, much like checking a company's report card before investing.

sedar+ regulatory

"For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR."

SEDAR+ is Canada’s centralized online system where publicly traded companies submit required regulatory documents such as financial reports, prospectuses and disclosure statements. It gives investors a single, searchable place — like a public library or online filing cabinet — to check a company’s official records for transparency, compare performance, and verify material information before making investment decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CALGARY, AB, April 13, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that senior executives and advisors of the Company will speak on panels at several upcoming cannabis and investor conferences across North America and Europe.

CONFERENCE & PANEL SCHEDULE

• Talman House
  Berlin – April 13, 2026 – Raj Grover
  A Shifting German Cannabis Landscape – 10:15 (GMT+2)

• International Cannabis Business Conference
  Berlin – April 14, 2026 – Raj Grover
  International Cannabis Investment Opportunities – 11:45 (GMT+2)
  
  Berlin – April 14, 2026 – Omar Khan
  Cannabis Advocacy and Lobbying – 15:45 (GMT+2)

• D. Boral Capital Conference
  New York – May 7, 2026 – Vahan Ajamian

• Cannabis Europa
  London – May 26, 2026 – Raj Grover
  Deal Flow & Due Diligence: Inside Europe's Next M&A Wave – 14:00 (GMT+1)
   
• TD Cowen Future of the Consumer Conference
  New York – June 2, 2026 – Vahan Ajamian – 9:30 (EDT)
   
• Planet MicroCap
  Las Vegas – June 17, 2026 – Raj Grover – 10:00 (EDT)

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 220 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.

Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CONTACT INFORMATION

Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-to-present-at-several-major-international-cannabis-and-investor-conferences-302740050.html

SOURCE High Tide Inc.

FAQ

Which High Tide executives will speak at the Berlin conferences on April 13–14, 2026 (HITI)?

Raj Grover and Omar Khan will speak at Berlin events on April 13–14, 2026. According to the company, Raj Grover covers market opportunities while Omar Khan addresses advocacy and lobbying panels during those dates.

When will High Tide (HITI) present at U.S. investor conferences in May and June 2026?

High Tide plans U.S. presentations on May 7 and June 2, 2026. According to the company, Vahan Ajamian will represent High Tide at the D. Boral Capital conference (May 7) and TD Cowen conference (June 2).

What does High Tide say about its retail footprint for investors (HITI)?

High Tide highlights Canna Cabana operates 220 Canadian stores and 1 international location. According to the company, the brand holds an expanding 12% share of the Canadian market across five provinces.

How does High Tide describe its medical cannabis distribution reach (HITI)?

High Tide states Remexian Pharma is licensed to import medical cannabis from 19 countries. According to the company, Remexian supplies wholesale medical cannabis at accessible prices across Germany.

Where and when will High Tide (HITI) appear in Europe in late May 2026?

High Tide will present at Cannabis Europa in London on May 26, 2026. According to the company, Raj Grover will speak on Europe's M&A wave and deal due diligence at that event.